HealthEquity EBITDA 2014-2025 | HQY
HealthEquity annual and quarterly EBITDA history from 2014 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- HealthEquity EBITDA for the quarter ending October 31, 2025 was $0.118B, a 93.91% increase year-over-year.
- HealthEquity EBITDA for the twelve months ending October 31, 2025 was $0.450B, a 39.35% increase year-over-year.
- HealthEquity 2025 annual EBITDA was $0.327B, a 19.45% increase from 2024.
- HealthEquity 2024 annual EBITDA was $0.274B, a 57.69% increase from 2023.
- HealthEquity 2023 annual EBITDA was $0.174B, a 47.8% increase from 2022.
|
HealthEquity Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $327 |
| 2024 | $274 |
| 2023 | $174 |
| 2022 | $117 |
| 2021 | $155 |
| 2020 | $135 |
| 2019 | $96 |
| 2018 | $70 |
| 2017 | $54 |
| 2016 | $35 |
| 2015 | $23 |
| 2014 | $16 |
| 2013 | $10 |
|
HealthEquity Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-10-31 | $118 |
| 2025-07-31 | $128 |
| 2025-04-30 | $122 |
| 2025-01-31 | $82 |
| 2024-10-31 | $61 |
| 2024-07-31 | $103 |
| 2024-04-30 | $81 |
| 2024-01-31 | $78 |
| 2023-10-31 | $69 |
| 2023-07-31 | $64 |
| 2023-04-30 | $63 |
| 2023-01-31 | $54 |
| 2022-10-31 | $47 |
| 2022-07-31 | $39 |
| 2022-04-30 | $33 |
| 2022-01-31 | $12 |
| 2021-10-31 | $34 |
| 2021-07-31 | $33 |
| 2021-04-30 | $37 |
| 2021-01-31 | $30 |
| 2020-10-31 | $42 |
| 2020-07-31 | $39 |
| 2020-04-30 | $44 |
| 2020-01-31 | $43 |
| 2019-10-31 | $30 |
| 2019-07-31 | $30 |
| 2019-04-30 | $32 |
| 2019-01-31 | $21 |
| 2018-10-31 | $24 |
| 2018-07-31 | $26 |
| 2018-04-30 | $25 |
| 2018-01-31 | $13 |
| 2017-10-31 | $18 |
| 2017-07-31 | $20 |
| 2017-04-30 | $19 |
| 2017-01-31 | $10 |
| 2016-10-31 | $12 |
| 2016-07-31 | $16 |
| 2016-04-30 | $16 |
| 2016-01-31 | $7 |
| 2015-10-31 | $8 |
| 2015-07-31 | $9 |
| 2015-04-30 | $10 |
| 2015-01-31 | $4 |
| 2014-10-31 | $6 |
| 2014-07-31 | $6 |
| 2014-04-30 | $7 |
| 2014-01-31 | |
| 2013-10-31 | $5 |
| 2013-07-31 | $4 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.312B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |